LIFECOME(SZ:002868) Mei Ri Jing Ji Xin Wen·2025-09-05 09:25Group 1 - The controlling shareholder of *ST Lvkang, Shanghai Kangyi Investment Co., Ltd., holds 47,291,400 shares, accounting for 30.43% of the total share capital [1] - The recent pledge extension involves 5,200,000 shares, representing 11.00% of the shares held by the controlling shareholder and 3.35% of the total share capital [1] - After the pledge extension, the total pledged shares by the controlling shareholder and its concerted parties amount to approximately 10.34 million shares, which is 21.08% of their holdings and 6.65% of the total share capital [1] Group 2 - For the first half of 2025, *ST Lvkang's revenue composition is as follows: veterinary medicine 61.79%, photovoltaic film 26.1%, biopesticides 5.99%, others 2.83%, and food additives 2.19% [1] - As of the report date, *ST Lvkang's market capitalization is 4.1 billion [1]